PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 2020EuroIntervention13 citations

Usefulness of mean pulmonary artery pressure for predicting outcomes of transcatheter closure of atrial septal defect with pulmonary arterial hypertension

View Full Paper
WPWenzhi PanYZYuan ZhangLGLihua Guan

Key Result

A baseline mean pulmonary artery pressure cut-off of 35.0 mmHg strongly predicted a positive response to transcatheter ASD closure without PAH-specific medicine (AUC 0.919, p<0.001).

Study Design

Type

Cohort (n=209)

Structured PICO

Can mean pulmonary artery pressure (MPAP) predict a positive response to transcatheter closure in adult patients with atrial septal defect and pulmonary arterial hypertension?

P
Population
209 adult patients with atrial septal defect (ASD) and pulmonary arterial hypertension (PAH) who underwent a successful transcatheter closure procedure without PAH-specific medicine
I
Intervention
Measurement of mean pulmonary artery pressure (MPAP) during attempted transcatheter closure of ASD, with or without administration of inhaled iloprost
O
Outcome
Positive response after attempted occlusion (defined as MPAP ≤30 mmHg or decrement percentage ≥20% compared with baseline)surrogate

Mean pulmonary artery pressure (MPAP) with a cut-off of 35.0 mmHg (or 50.0 mmHg with inhaled iloprost) is a strong predictor of successful transcatheter closure in adult ASD patients with PAH.

Main Result

Absolute Event Rate: 14% vs 79.4%

p-value: p=<0.001

Abstract

AIMS: This study aimed to provide a simple index for predicting the definitive indication for transcatheter closure of atrial septal defect (ASD) with pulmonary arterial hypertension (PAH). METHODS AND RESULTS: A positive response after attempted occlusion was defined as mean pulmonary artery pressure (MPAP) ≤30 mmHg or the decrement percentage of it ≥20% compared with baseline. If a positive response was achieved, the occluder would be released, and the procedure was defined as successful. In 209 patients who underwent a successful procedure without PAH-specific medicine, there was a dramatic decrease in the percentage of patients with pulmonary arterial systolic pressure (PASP) ≥50 mmHg from baseline to the one-year follow-up (79.4% to 14.0%, p<0.001). The optimal cut-off value of MPAP to predict a positive response without PAH-specific medicine was 35.0 mmHg, with an area under the curve (AUC) of 0.919 (p<0.001). Administration of inhaled iloprost extended the cut-off point to 50.0 mmHg to reach a positive response, with an AUC of 0.774 (p=0.003). CONCLUSIONS: This large-scale study indicated that MPAP could be a simple but powerful index to predict benefit from closure in adult ASD patients with PAH.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pan et al. (2020) conducted a cohort in Atrial septal defect with pulmonary arterial hypertension (n=209). Transcatheter closure of atrial septal defect vs. Baseline was evaluated on Pulmonary arterial systolic pressure (PASP) ≥50 mmHg (p=<0.001). A baseline mean pulmonary artery pressure cut-off of 35.0 mmHg strongly predicted a positive response to transcatheter ASD closure without PAH-specific medicine (AUC 0.919, p<0.001).

synapsesocial.com/papers/6a1c5b6126cb5670aa9db859https://doi.org/10.4244/eij-d-19-00172
Ask AI
Helpful
Bookmark
Share
View Full Paper